The mechanisms of action of monoclonal antibodies and intravenous immunoglobulin include cytolysis of target cells through complement or antibody-dependent cell-mediated cytotoxicity, induction of ...
“Monoclonal antibodies are our core competence ... The ADLib system generates diversity in the immunoglobulin gene through gene conversion, enhanced by trichostatin A (TSA) treatment.
Immunoglobulin M monoclonal gammopathy of undetermined significance (IgM-MUS) was diagnosed in 213 Mayo Clinic patients who were residents of 11 counties in southeastern Minnesota from 1960 to 1994.
Due to their extraordinary specificity and pharmacokinetic (PK) behavior, human immunoglobulin gamma monoclonal antibodies (hIgG mAbs) are a most promising biological therapy for treating an ...
Monoclonal gammopathy of undetermined significance was diagnosed in 213 Mayo Clinic patients from 1960 to 1994 who were residents of 11 counties in southeastern Minnesota.2,6 Fifty-eight percent ...
particularly due to its early-stage development of novel IgM antibodies, which are yet to be proven as viable therapeutic options. The company is confronted with challenges such as the high costs ...
Mexican health authority approves Leqembi for the treatment of early Alzheimer’s disease: Tokyo Friday, December 6, 2024, 14:00 Hrs [IST] Eisai Co., Ltd. and Biogen Inc. announc ...
Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children: Tokyo Saturday, November 23, 2024, 10:00 Hrs [IST] Zenyaku Ko ...
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics License Application (BLA) in the U.S. for ...